Preferentially Expressed Antigen in Melanoma (PRAME) as a diagnostic and predictive marker in melanocytic tumors: An updated narrative review.
Serena Salzano(University of Catania), Giuseppe Broggi(University of Catania), Nektarios Koufopoulos(National and Kapodistrian University of Athens), Magda Zanelli(Azienda Sanitaria Unità Locale di Reggio Emilia), Rosario Caltabiano(University of Catania), Andrea Palicelli(Azienda Sanitaria Unità Locale di Reggio Emilia), Maurizio Zizzo(Azienda Sanitaria Unità Locale di Reggio Emilia)
Cited by 2
Related Papers
CircSMARCA5 Regulates VEGFA mRNA Splicing and Angiogenesis in Glioblastoma Multiforme Through the Binding of SRSF1
|Cancers|2019|230
Surgical Treatment of Spasticity in Cerebral Palsy
|Pediatric Neurosurgery|1978|166
Serum Extracellular Vesicle-Derived circHIPK3 and circSMARCA5 Are Two Novel Diagnostic Biomarkers for Glioblastoma Multiforme
|Pharmaceuticals|2021|108